Marker seed migration in prostate localization.

PURPOSE Marker seed location was analyzed to test the hypothesis that there is no intraseed migration within the prostate, a premise fundamental to the technique of marker seed localization of this organ. Despite increasing interest in the use of implanted seeds as fiducial markers for gland location, there are few data available with which to evaluate the validity of this technique, particularly over the entire course of external beam radiation therapy. METHODS AND MATERIALS Between May 2001 and December 2001, after obtaining fully informed written consent, 9 patients with early stage prostate cancer were enrolled on an institutionally reviewed protocol. Patients had four to five marker seeds implanted into the prostate under transrectal ultrasound guidance before definitive radiotherapy. The porous gold seeds were each 1.2 x 2.0 mm in dimension. Seed locations from orthogonal radiographs based on the initial simulation and weekly orthogonal films were digitized using a CMS Focus planning system, thereby facilitating the determination of intraseed spacing. The digitization of the isocenter from each orthogonal pair of radiographs was used to determine digitizing error for seed localization. Pubic symphysis, bilateral femoral heads, and isocenter were also digitized and will be analyzed at a later date. RESULTS Overall, the average migration of all the seeds in the patients was 1.2 +/- 0.2 (SD) mm. The greatest average movement of any seed in any patient was 1.9 mm over the entire 7-week course of radiotherapy. The smallest average movement was 0.6 mm. The greatest change in intraseed spacing in any of the patients during the full course of therapy was 6.6 mm. One seed in 1 patient was lost at the start of the third week of therapy and censored from analysis. Digitizing error in seed localization was calculated to be 0.20 +/- 0.03 (SD) mm. CONCLUSIONS As an aggregate, there is negligible seed migration within the prostate over the entire course of definitive radiotherapy. However, there are small, detectable movements in individual seed locations, perhaps resulting from topographic changes in the gland secondary to seed placement, anatomic changes in bladder and rectum, or treatment itself. With respect to seed migration, prostate marker seeds represent an accurate and reliable surrogate of gland location during a full course of radiotherapy.

[1]  H M Sandler,et al.  Localization of the prostatic apex for radiation therapy using implanted markers. , 1993, International journal of radiation oncology, biology, physics.

[2]  J M Balter,et al.  A comparison of ventilatory prostate movement in four treatment positions. , 2000, International journal of radiation oncology, biology, physics.

[3]  J Szanto,et al.  Respiratory-induced prostate motion: quantification and characterization. , 2000, International journal of radiation oncology, biology, physics.

[4]  K L Lam,et al.  Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. , 1995, International journal of radiation oncology, biology, physics.

[5]  W. Butler,et al.  Seed fixity in the prostate/periprostatic region following brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[6]  M Wannenmacher,et al.  Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. , 1988, International journal of radiation oncology, biology, physics.

[7]  G J Kutcher,et al.  Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. , 1997, International journal of radiation oncology, biology, physics.

[8]  R. Zellars,et al.  Prostate position late in the course of external beam therapy: patterns and predictors. , 2000, International journal of radiation oncology, biology, physics.

[9]  P Kijewski,et al.  Analysis of prostate and seminal vesicle motion: implications for treatment planning. , 1996, International journal of radiation oncology, biology, physics.

[10]  K. Wallner,et al.  Time-dependent changes in CT-based dosimetry of I-125 prostate brachytherapy. , 1998, Radiation oncology investigations.

[11]  Randall K Ten Haken,et al.  Daily prostate targeting using implanted radiopaque markers. , 2001, International journal of radiation oncology, biology, physics.

[12]  T Haycocks,et al.  Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  J Pouliot,et al.  Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.

[14]  J. Crook,et al.  Prostate motion during standard radiotherapy as assessed by fiducial markers. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  C. Coleman,et al.  Analysis of prostate and seminal vesicle motion , 1993 .

[16]  M van Herk,et al.  Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. , 1995, International journal of radiation oncology, biology, physics.